Disclosures for "The contribution of thalamic pathology to the clinical manifestations of frontotemporal dementia phenotypes")
-
Dr. McKenna has nothing to disclose.
-
Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva.
-
Dr. Bede has nothing to disclose.